MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition
March 23, 2026 11:00 AM EDTBelieves the Boards Decision to Remove CEO Peter Greenleaf and Install Kevin Tang as CEO Validates Multi-Year Shareholder Campaign
Commends New Leaderships Commitment to Shareholder Alignment Through Zero CEO Compensation
Expects Aurinia to Enter New Chapter of Disciplined Capital Allocation and Value Creation
CAYMAN ISLANDS--(BUSINESS WIRE)-- MKT Capital Ltd. (together with its affiliates, MKT Capital or we), a significant long-term shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today issued the following statement in response to the Companys announcement... More
